Fugitive arrested in alleged $547 million Medicare genetic-testing fraud scheme

Federal authorities have arrested and transferred to U.S. custody Khalid Ahmed Satary, a defendant in an alleged Medicare fraud scheme that prosecutors say generated more than $547 million in claims or losses through medically unnecessary genetic testing.

Satary was apprehended on July 20, 2026, according to the U.S. Department of Justice. After his transfer, he appeared in federal court in the Eastern District of Virginia. The department announced the arrest on July 21.

The case reaches back to an indictment returned in 2019 in the Eastern District of Louisiana. That indictment alleges that the operation ran from 2016 through 2019 and used diagnostic laboratories to bill Medicare for genetic tests that patients did not medically need.

What authorities allege

According to the Justice Department’s description of the case, the alleged operation relied on a network that included patient recruiters, telemarketing call centers and telemedicine companies. Authorities also allege that illegal kickbacks were part of the scheme.

The alleged laboratories and billing operation operated throughout the United States. The department’s account describes the case as involving more than $547 million in Medicare claims or losses. The precise amount ultimately provable as a loss could differ from the amount described in the indictment and public release.

Medicare is the federal health program at the center of the alleged billing activity. The case therefore concerns not only alleged criminal conduct, but also the use of a public program to pay for services that prosecutors say were unnecessary.

Charges and legal status

Satary faces charges including conspiracy to commit health-care fraud and wire fraud, health-care fraud, kickbacks-related offenses and money laundering. Some of the charged conspiracy counts carry potential sentences of up to 20 years, according to the approved case information.

The arrest and court appearance are procedural developments, not a finding that Satary committed the alleged fraud. The Justice Department’s account describes allegations in an indictment, and guilt has not been established in court.

The distinction matters in a case involving a figure as large as $547 million. The amount represents the alleged scale described by the department, not a final court determination of loss or an amount that has been recovered. The approved information does not report that any of the alleged losses have been recovered.

What happens next

Satary’s appearance in the Eastern District of Virginia follows his transfer into U.S. custody. The case now proceeds through the federal court process on the charges described by prosecutors, while the allegations remain subject to litigation and proof in court.

The Justice Department has not identified in the approved announcement a next hearing date or other specific deadline. The case’s immediate significance is the movement of a defendant indicted in 2019 into U.S. custody, alongside renewed public attention to an alleged nationwide scheme involving Medicare billing, genetic testing and kickbacks.

The prosecution also illustrates the federal government’s ability to pursue alleged health-care fraud across jurisdictions. The indictment was filed in the Eastern District of Louisiana, Satary appeared in the Eastern District of Virginia, and the alleged laboratories and billing operation operated throughout the United States.